瑞德系统(R)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

R 瑞德系统

休市中 08-21 16:00:00 EDT

249.73

+1.88

+0.76%

盘后249.73

+0.000.00%

19:30 EDT

最高250.96	最低246.89	成交量36.87万
今开250.56	昨收247.85	日振幅1.64%
总市值95.76亿	流通市值92.03亿	总股本3,835万
成交额9,192万	换手率1.00%	流通股本3,685万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"R","market":"US","secType":"STK","nameCN":"瑞德系统","latestPrice":249.73,"timestamp":1787342400000,"preClose":247.85,"halted":0,"volume":368725,"hourTrading":{"tag":"盘后","latestPrice":249.73,"preClose":249.73,"latestTime":"19:30 EDT","volume":9975,"amount":2491053.51,"timestamp":1787355003488,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0075852330038329455,"floatShares":36853364,"shares":38346868,"eps":12.325055,"marketStatus":"休市中","change":1.88,"latestTime":"08-21 16:00:00 EDT","open":250.56,"high":250.96,"low":246.8882,"amount":91916719.3105,"amplitude":0.016428,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":12.325055,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-292968000000,"exchange":"NYSE","adjPreClose":247.85,"dividendRate":0.014576,"preHourTrading":{"tag":"盘前","latestPrice":254.5,"preClose":247.85,"latestTime":"08:59 EDT","volume":5,"amount":1245.90005,"timestamp":1787317140103,"change":6.65,"changeRate":0.026831,"amplitude":0.026831},"postHourTrading":{"tag":"盘后","latestPrice":249.73,"preClose":249.73,"latestTime":"19:30 EDT","volume":9975,"amount":2491053.51,"timestamp":1787355003488,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3032034644722676,"impliedVol":0.3136,"impliedVolPercentile":0.2151},"requestUrl":"/m/hq/s/R/tweets","defaultTab":"tweets","newsList":[{"id":"1160126283","title":"新闻稿：复宏汉霖发布2026年中期业绩——盈利持续跃升，全球价值兑现加速，迈向C-MNC步伐加快","url":"https://stock-news.laohu8.com/highlight/detail?id=1160126283","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160126283?lang=zh_cn&edition=full","pubTime":"2026-08-21 21:03","pubTimestamp":1787317411,"startTime":"0","endTime":"0","summary":"上海，2026年8月21日 /PRNewswire/ -- 8月21日，复宏汉霖公布其2026财年中期业绩。2026年上半年，复宏汉霖实现非国际财务报告准则利润人民币5.723亿元，同比大幅增长46.7%；调整后息税折旧摊销前利润为人民币9.041亿元，同比增长35.2%。关键财务及运营指标保持稳健上行态势。得益于核心产品在全球市场的持续放量，以及全价值链端到端的精益运营，公司的收入规模与盈利质量正同步增强。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK4099","BK4604","BK4205","BK4555","HK0000320264.USD","HK0000306685.HKD","BK4097","UK","PRGS","BK4588","TM","BK4233","BK4585","BK4022","HK0000306701.USD","R","BK1161","BK4528","02696","HK0000320223.HKD","LU2065732104.USD","03160","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113095677","title":"LifeVantage宣布季度股息派发计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1113095677","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113095677?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:03","pubTimestamp":1787313829,"startTime":"0","endTime":"0","summary":"盐湖城，2026年8月21日——LifeVantage Corporation，一家致力于通过细胞层面激活最佳健康过程的领先健康与保健公司，今日宣布其董事会已批准每股普通股0.050美元的季度现金股息。该股息将于2026年9月15日支付，登记截止日为2026年9月1日营业结束时在册的所有股东。LifeVantage Corporation，作为“激活”领域的先锋企业，是营养基因组学的开创者——这一学科研究营养及天然化合物如何解锁基因及其内在的健康密码。LifeVantage成立于2003年，总部位于犹他州莱希市。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4022","BK4232","LFVN","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163692170","title":"Meritage Homes宣布季度现金股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1163692170","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163692170?lang=zh_cn&edition=full","pubTime":"2026-08-21 02:50","pubTimestamp":1787251837,"startTime":"0","endTime":"0","summary":"亚利桑那州斯科茨代尔，2026年8月20日——美国第五大住宅建筑商Meritage Homes Corporation今日宣布，其董事会已批准派发每股0.48美元的季度股息。该股息将于2026年9月30日支付，登记截止日期为2026年9月15日交易收盘时。Meritage是美国第五大上市住宅建筑商，该排名基于2025年交付的房屋数量。在41年的发展历程中，Meritage已累计交付超过21万套住宅，并以其独特的设计风格、优质的施工质量以及屡获殊荣的客户体验而闻名。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTH","BK4022","BK4232","BK4088","R","XHB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147388028","title":"新闻稿：Lifetime Brands宣布完成6000万美元第二留置权定期贷款及2亿美元ABL融资额度的修订与展期","url":"https://stock-news.laohu8.com/highlight/detail?id=1147388028","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147388028?lang=zh_cn&edition=full","pubTime":"2026-08-18 04:16","pubTimestamp":1786997805,"startTime":"0","endTime":"0","summary":"纽约州加登城，2026年8月17日——生活时光品牌家具作为全球领先的家居品牌消费品设计商、开发商和营销商，今日宣布已完成其信贷设施的再融资。该公司现有的B期定期贷款已被一笔由Pathlight Capital提供的新6000万美元第二留置权定期贷款所取代，同时，由摩根大通担任代理行的2亿美元资产基础循环信贷额度也已获得修订和展期。新第二留置权定期贷款与修订后的ABL融资额度均于2031年8月到期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4180","BK4604","BK4022","BK4555","BK4099","TM","BK4585","03160","BK4232","LCUT","PRTO","R","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166097486","title":"Madrigal任命John C. Reed博士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1166097486","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166097486?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:03","pubTimestamp":1786536220,"startTime":"0","endTime":"0","summary":"康舍霍肯，宾夕法尼亚州，2026年8月12日——专注于代谢功能障碍相关脂肪性肝炎新型疗法开发的生物制药公司Madrigal Pharmaceuticals, Inc.今日宣布，已任命John C. Reed医学博士、哲学博士为其董事会成员。Reed博士目前担任强生公司创新医学研发执行副总裁，并是J&J执行委员会成员。Madrigal董事会主席Julian Baker表示：\"非常欢迎John Reed加入Madrigal。Madrigal首席执行官Bill Sibold补充道：\"John的任命体现了Madrigal对科学卓越和长期创新的持续承诺。Madrigal Pharmaceuticals、Rezdiffra及相关标识均为Madrigal Pharmaceuticals, Inc.的商标。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","MDGL","R","BK4588","BK4022","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193936221","title":"数字房地产信托公司宣布普通股与优先股季度现金股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1193936221","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193936221?lang=zh_cn&edition=full","pubTime":"2026-08-12 04:10","pubTimestamp":1786479046,"startTime":"0","endTime":"0","summary":"德克萨斯州奥斯汀，2026年8月11日 —— 全球最大的云和运营商中立数据中心平台——数字房地产信托公司今日宣布，其董事会已授权2026年第三季度普通股及优先股的季度现金股息。数字房地产信托公司董事会批准，向截至2026年9月15日营业结束时登记在册的普通股股东，派发每股1.22美元的现金股息。数字房地产信托公司通过提供全面的数据中心、主机托管和互联解决方案，将企业与数据紧密连接。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","WTRE","JRE","DTCR","IYRI","RITA","R","PPTY","BK4022","JPRE","BK4232","IYR","USRT","PSR","RNTY","SCHH","BK4566","VIG","BK4529","SRVR","BK4084","FRI","DLR","IDGT","REAI","REET","BK4222","CRED","RWO","DTRE","BBRE","VGSR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168267209","title":"Duos Technologies集团完成向Sandbank Acosta出售子公司Duos Technologies的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1168267209","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168267209?lang=zh_cn&edition=full","pubTime":"2026-08-07 04:39","pubTimestamp":1786048776,"startTime":"0","endTime":"0","summary":"佛罗里达州杰克逊维尔，2026年8月6日 —— Duos Technologies集团，一家领先的自适应、模块化及可扩展边缘数据中心解决方案提供商，今日宣布已完成将其全资铁路技术子公司——Duos Technologies出售给佛罗里达有限责任公司Sandbank Acosta。交易完成后，DTI将以DuosTI品牌作为一家独立的私营公司运营，由新任总裁Javier Acosta领导。此次剥离完成了Duos在2026年3月宣布的战略重组，使公司能够将资源集中于边缘数据中心和AI基础设施业务，具体由Duos Edge AI和Duos Technology Solutions两家子公司负责。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIBU","QTOC","BK4022","AIPO","AGIX","VTHR","BK4232","CHAT","BERZ","ARTY","R","BK4097","DUOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193281325","title":"新闻稿：Rani Therapeutics 任命 Michelle Gilson 加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1193281325","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193281325?lang=zh_cn&edition=full","pubTime":"2026-08-04 20:12","pubTimestamp":1785845578,"startTime":"0","endTime":"0","summary":"加利福尼亚州圣何塞，2026年8月4日——专注于口服生物制剂递送的临床阶段生物治疗公司 Rani Therapeutics Holdings, Inc.今日宣布，任命 Michelle Gilson 为其董事会成员。Gilson 女士将担任审计委员会主席。“Michelle 兼具深厚的资本市场专业知识和在高增长生物技术公司担任财务领导的实际经验，这使她成为我们董事会的一位卓越新成员，”Rani Therapeutics 首席执行官 Talat Imran 表示。“能在公司如此关键的时期加入 Rani Therapeutics 董事会，我深感荣幸，”Michelle Gilson 说道。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","R","BK4139","BK4007","LENZ","BK4539","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187966317","title":"赛托姆X疗法任命亚历杭德拉·卡瓦哈尔为首席法务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1187966317","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187966317?lang=zh_cn&edition=full","pubTime":"2026-08-03 20:02","pubTimestamp":1785758545,"startTime":"0","endTime":"0","summary":"——在掩蔽型、条件性激活生物制剂领域处于领先地位的赛托姆X疗法公司，今日正式宣布任命亚历杭德拉·卡瓦哈尔为首席法务官。在此职位上，卡瓦哈尔女士将全力支持公司的战略规划、运营执行及管线项目推进。“在这个关键节点，能够加入赛托姆X并为其愿景贡献力量，我倍感振奋，”卡瓦哈尔女士说道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4022","R","CTMX","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107772972","title":"新闻稿：Medicus Pharma 任命 Faisal Mehmud 博士为英国子公司 Antev Limited 首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1107772972","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107772972?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:33","pubTimestamp":1785756837,"startTime":"0","endTime":"0","summary":"费城，2026年8月3日——生物科技与生命科学公司 Medicus Pharma Ltd.今日宣布，任命Faisal Mehmud医学博士、皇家内科医师学会会员为英国子公司Antev Limited的首席执行官，自2026年8月30日起生效。该公司专注于推进新型且潜在颠覆性治疗资产的临床开发项目。Mehmud博士将继续担任Medicus的首席医疗官和Antev的联合主席。此次任命进一步加强了Medicus的整合领导架构。Mehmud博士接替了Amit Kohli，后者自2025年8月29日Medicus完成对Antev的收购以来一直担任临时首席执行官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UK","BK4567","BK4022","MDCX","BK4211","UBCP","BK4528","BCC","BK4232","BK4104","BK4233","BK4205","R","BK4139","MRCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130963768","title":"新闻稿：Seer股东投票全数通过，2026年度股东大会七位董事候选人成功连任","url":"https://stock-news.laohu8.com/highlight/detail?id=1130963768","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130963768?lang=zh_cn&edition=full","pubTime":"2026-07-29 05:41","pubTimestamp":1785274872,"startTime":"0","endTime":"0","summary":"加利福尼亚州雷德伍德城，2026年7月28日——Seer, Inc.今日宣布，根据2026年度股东大会的初步投票结果，公司股东已投票决定，全数通过七位董事候选人的连任提案。这七位候选人分别是：Omid Farokhzad、Meeta Gulyani、Robert Langer、Terrance McGuire、Dipchand  Nishar、Isaac Ro以及Nicolas Roelofs。他们将共同组成Seer的董事会。今日公布的投票结果仅为初步数据，最终结果将由独立选举监察员进行统计和认证。此类前瞻性声明基于Seer的信念和假设，以及截至本通讯发布之日其可获得的信息。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","SEER","BK4022","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197206772","title":"纳斯制药任命资深药企高管 Brendan P. O'Grady 为首席执行官，引领战略增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1197206772","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197206772?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:35","pubTimestamp":1785238543,"startTime":"0","endTime":"0","summary":"以色列特拉维夫，2026年7月28日——纳斯制药有限公司是一家专注于创新鼻内产品开发的临床阶段制药公司。今日，该公司宣布任命药界资深人士 Brendan P. O'Grady 为其新任首席执行官。O'Grady 先生将引领公司迈入下一增长阶段，其首要任务是释放 NS002 的商业潜力，推进公司产品管线及业务发展计划，并最大化其专有 Nasax 鼻内给药技术平台的价值。此次领导层交接已于2026年7月27日生效，O'Grady 先生接替 Dan Teleman 的职务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4022","BK4007","DBB","NSRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100422595","title":"新闻稿：CytomX Therapeutics 任命 Charles Fuchs 医学博士、公共卫生学硕士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1100422595","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100422595?lang=zh_cn&edition=full","pubTime":"2026-07-27 20:01","pubTimestamp":1785153661,"startTime":"0","endTime":"0","summary":"南旧金山，加利福尼亚州，2026年7月27日—— 隐蔽型、条件性激活生物制剂领域的领军企业 CytomX Therapeutics, Inc.今日宣布，任命 Charles Fuchs 医学博士、公共卫生学硕士为其董事会成员。他是一名获得认证的医学肿瘤学家，拥有哈佛医学院的医学博士学位和哈佛 T.H. Chan 公共卫生学院的公共卫生学硕士学位。通过其 PROBODY 治疗平台开创一条创新的局部化生物制剂管线，CytomX 的愿景是为癌症治疗创造更安全、更有效的疗法。CytomX 的临床阶段管线包括 varsetatug masetecan和 CX-801。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTMX","BK4022","BK4232","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653728541","title":"莱德系统(R)二季度总收入达33.47亿美元 同比增长5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653728541","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653728541?lang=zh_cn&edition=full","pubTime":"2026-07-23 20:38","pubTimestamp":1784810310,"startTime":"0","endTime":"0","summary":"财报显示，截至2026年6月30日的第二季度，莱德系统二季度实现总收入 33.47亿美元，同比增长 5%；剔除燃油及外包运输服务后的非GAAP营业收入为 26.86亿美元，同比增长 3%，主要由供应链业务的合同拓展所驱动。GAAP持续经营每股收益达 3.40美元，同比增长 8%。同时，二季度持续经营活动产生的经营现金流为 13亿美元，且由于资本支出减少，非GAAP自由现金流大幅增至 6.84亿美元。","market":"other","thumbnail":"https://static.szfiu.com/news/20210625/OTQxMjY5MjE5MzQ5Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTQxMjY5MjE5MzQ5Nw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302957","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118709529","title":"瑞德系统二季度计提1000万美元有限寿命无形资产非现金减值损失","url":"https://stock-news.laohu8.com/highlight/detail?id=1118709529","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118709529?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:57","pubTimestamp":1784804235,"startTime":"0","endTime":"0","summary":"瑞德系统在第二季度财报中确认了一笔价值1000万美元的非现金减值支出，该项支出针对一项具有明确使用年限的无形资产。此类资产减值通常反映了公司对特定无形资产未来经济效益预期的下调，或表明其账面价值可能已无法完全通过未来使用或处置得以回收。财务处理上，这笔非现金费用将直接影响当季利润表，减少公司报告期内的净利润，但不会对当期的经营性现金流产生直接影响。投资者在评估公司核心运营表现时，往往需要关注此类非经常性项目对业绩的短期影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125084585","title":"财报前瞻｜瑞德系统本季度营收预计增3.80%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1125084585","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125084585?lang=zh_cn&edition=full","pubTime":"2026-07-16 09:59","pubTimestamp":1784167154,"startTime":"0","endTime":"0","summary":"瑞德系统将于2025年07月23日发布最新季度财报，市场关注盈利修复与服务业务动能。市场一致预期瑞德系统本季度营收为32.93亿美元，同比增长3.80%；调整后每股收益为3.68美元，同比增长18.45%；息税前利润为2.83亿美元，同比增长7.64%；若公司未在上季度财报中提供本季度毛利率、净利润或净利率及调整后每股收益的具体预测，则不予展示相关预测数据。本季度营收预计增长3.80%，若燃料相关成本与供应链费用保持平稳，毛利率具备维持或温和改善的基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜瑞德系统本季度营收预计增3.80%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127897452","title":"新闻稿：Tarsus Pharmaceuticals 宣布高管领导层变动，公司迈入增长新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1127897452","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127897452?lang=zh_cn&edition=full","pubTime":"2026-07-14 04:13","pubTimestamp":1783973630,"startTime":"0","endTime":"0","summary":"加州尔湾，2026年7月13日——Tarsus Pharmaceuticals, Inc.  今日宣布，首席商务官Aziz Mottiwala将离职，以出任一家上市医疗器械公司的首席执行官，寻求新的职业发展。此次领导层变动正值Tarsus进入新的增长阶段。本新闻稿中包含的任何前瞻性陈述均基于Tarsus管理团队当前的预期，且仅代表截至发布之日的情况。Tarsus明确声明，除非法律要求，否则没有义务因新信息、未来事件或其他原因而更新任何前瞻性陈述。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4232","TARS","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183275253","title":"Pliant Therapeutics任命Flavia Borellini博士和Robert Iannone博士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1183275253","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183275253?lang=zh_cn&edition=full","pubTime":"2026-07-13 20:35","pubTimestamp":1783946106,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Pliant Therapeutics今日宣布，任命Flavia Borellini博士与Robert Iannone博士为公司董事会新成员。这两项任命为董事会注入了深厚的全球肿瘤药物开发经验，并进一步强化了其在运营与监管事务方面的专业能力。目前，除了在Pliant任职外，他还担任Autolus Therapeutics的董事会成员。关于Pliant Therapeutics, Inc.：Pliant Therapeutics是一家临床阶段的生物制药公司，专注于基于整合素的疗法的发现与开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","BK4588","BK4585","LENZ","IBB","R","BK4232","BK4022","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121444252","title":"新闻稿：ARS Pharmaceuticals宣布首席执行官继任计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1121444252","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121444252?lang=zh_cn&edition=full","pubTime":"2026-07-08 04:31","pubTimestamp":1783456303,"startTime":"0","endTime":"0","summary":"致力于赋能高危患者及其护理人员、以更好地预防可能导致过敏性休克的过敏反应的生物制药公司ARS Pharmaceuticals, Inc.今日宣布首席执行官继任计划。联合创始人兼首席执行官理查德·洛温塔尔自2026年7月6日起，将不再担任公司雇员及高管职务。董事会已任命现任总裁唐恩·卡萨莱为首席执行官兼董事，自2026年7月7日起生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","SPRY","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649980847","title":"代表作累计回报超8倍  李巍新基广发匠心精选正在发售","url":"https://stock-news.laohu8.com/highlight/detail?id=2649980847","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649980847?lang=zh_cn&edition=full","pubTime":"2026-07-07 20:40","pubTimestamp":1783428000,"startTime":"0","endTime":"0","summary":"7月6日至7月24日，拟由20年长跑健将李巍担任基金经理的新产品——广发匠心精选混合型，在建设银行、广发基金直销等渠道正式发行。　　截至5月31日，李巍在管公募基金共7只，除了广发制造业精选和广发创业板两年定开混合以外，其余5只均为全市场基金。李巍在管7只基金，广发制造业精选混合成立日期为2011年9月20日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-07-07/doc-inifyvat1601895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03419","83115","82800","R","MCHmain","513600","MHImain","07200","02800","HSI","07500","HHImain","03115","03037","BK4022","BK4232","02833","09115","07300"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ryder.com;investors.ryder.com","stockEarnings":[{"period":"1week","weight":-0.0539},{"period":"1month","weight":-0.0964},{"period":"3month","weight":0.0235},{"period":"6month","weight":0.1146},{"period":"1year","weight":0.3842},{"period":"ytd","weight":0.3048}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"莱德系统公司是一家成立于1933年的佛罗里达州企业，是全球领先的运输和供应链管理解决方案提供商。该公司提供从港口到门的全流程解决方案，整合供应链的各个环节，包括国际入境物流和跨境物流、车队和运输管理、仓储、制造支持以及多渠道最终交付。其互补的业务板块提供广泛的增值解决方案，为客户打造无缝衔接的端到端物流网络，旨在降低复杂性，并提升整个货物流转的速度、可靠性和效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.019416},{"month":2,"riseRate":0.586957,"avgChangeRate":0.011618},{"month":3,"riseRate":0.565217,"avgChangeRate":0.006717},{"month":4,"riseRate":0.531915,"avgChangeRate":0.02614},{"month":5,"riseRate":0.531915,"avgChangeRate":0.008544},{"month":6,"riseRate":0.468085,"avgChangeRate":0.002602},{"month":7,"riseRate":0.595745,"avgChangeRate":0.031186},{"month":8,"riseRate":0.425532,"avgChangeRate":-0.007234},{"month":9,"riseRate":0.521739,"avgChangeRate":-0.006569},{"month":10,"riseRate":0.543478,"avgChangeRate":0.00111},{"month":11,"riseRate":0.630435,"avgChangeRate":0.027401},{"month":12,"riseRate":0.543478,"avgChangeRate":0.009358}],"exchange":"NYSE","name":"瑞德系统","nameEN":"Ryder"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞德系统(R)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞德系统(R)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞德系统,R,瑞德系统股票,瑞德系统股票老虎,瑞德系统股票老虎国际,瑞德系统行情,瑞德系统股票行情,瑞德系统股价,瑞德系统股市,瑞德系统股票价格,瑞德系统股票交易,瑞德系统股票购买,瑞德系统股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞德系统(R)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞德系统(R)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}